Physician profile
Scott Prose
NPI 1043353493
$9,424.42
in general payments reported to CMS, 2019-2025
8 companies · $280 in 2025
The $280 reported for 2025 was more than what a typical Orthodontics and Dentofacial Orthopedics provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,424 · 2020: $612 · 2021: $4,724 · 2022: $256 · 2023: $573 · 2024: $556 · 2025: $280.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,002 · Consulting Fee: $407.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,002.35 |
| Consulting Fee | $406.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ormco Corporation | $7,583.92 | 2019-2023 | Red, White and Blue Retainer, Damon, Spark |
| Align Technology, INC. | $1,213.75 | 2019-2025 | Invisalign Lens, Kit Assy, Invisalign |
| Envista Holdings Corporation | $235.37 | 2024-2025 | Damon, Spark, Miniendo II |
| Nobel Biocare USA | $218.68 | 2023 | Nobelactive |
| American Orthodontics Corporation | $74.21 | 2025 | Master Series, Radiance, Empower-Ceramic |
| Straumann USA LLC | $46.62 | 2021 | |
| Dentsply Sirona INC | $34.48 | 2024 | Astra Tech Implant System |
| Ortho Organizers, INC. | $17.39 | 2023 | Carriere |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Prose listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.